275 related articles for article (PubMed ID: 16291763)
21. Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.
Ntumngia FB; King CL; Adams JH
Int J Parasitol; 2012 Nov; 42(12):1055-62. PubMed ID: 23068913
[TBL] [Abstract][Full Text] [Related]
22. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain.
George MT; Schloegel JL; Ntumngia FB; Barnes SJ; King CL; Casey JL; Foley M; Adams JH
mSphere; 2019 May; 4(3):. PubMed ID: 31092602
[TBL] [Abstract][Full Text] [Related]
23. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.
Valderrama-Aguirre A; Quintero G; Gómez A; Castellanos A; Pérez Y; Méndez F; Arévalo-Herrera M; Herrera S
Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):16-24. PubMed ID: 16291762
[TBL] [Abstract][Full Text] [Related]
24. Preclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants.
Arévalo-Herrera M; Vera O; Castellanos A; Céspedes N; Soto L; Corradin G; Herrera S
Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):21-7. PubMed ID: 21292874
[TBL] [Abstract][Full Text] [Related]
25. Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys.
Castellanos A; Arévalo-Herrera M; Restrepo N; Gulloso L; Corradin G; Herrera S
Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):411-6. PubMed ID: 17568948
[TBL] [Abstract][Full Text] [Related]
26. Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein.
Michon P; Fraser T; Adams JH
Infect Immun; 2000 Jun; 68(6):3164-71. PubMed ID: 10816459
[TBL] [Abstract][Full Text] [Related]
27. Towards a vaccine against Plasmodium vivax malaria.
Beeson JG; Crabb BS
PLoS Med; 2007 Dec; 4(12):e350. PubMed ID: 18092888
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175.
Pattnaik P; Shakri AR; Singh S; Goel S; Mukherjee P; Chitnis CE
Vaccine; 2007 Jan; 25(5):806-13. PubMed ID: 17045706
[TBL] [Abstract][Full Text] [Related]
29. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations.
Tamborrini M; Stoffel SA; Westerfeld N; Amacker M; Theisen M; Zurbriggen R; Pluschke G
Malar J; 2011 Dec; 10():359. PubMed ID: 22166048
[TBL] [Abstract][Full Text] [Related]
31. Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein.
Ntumngia FB; Adams JH
Clin Vaccine Immunol; 2012 Jan; 19(1):30-6. PubMed ID: 22116684
[TBL] [Abstract][Full Text] [Related]
32. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1
Rocha MV; Françoso KS; Lima LC; Camargo TM; Machado RLD; Costa FTM; Rénia L; Nosten F; Russell B; Rodrigues MM; Soares IS
Vaccine; 2017 Apr; 35(18):2463-2472. PubMed ID: 28341111
[TBL] [Abstract][Full Text] [Related]
33. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
Wu Y; Ellis RD; Shaffer D; Fontes E; Malkin EM; Mahanty S; Fay MP; Narum D; Rausch K; Miles AP; Aebig J; Orcutt A; Muratova O; Song G; Lambert L; Zhu D; Miura K; Long C; Saul A; Miller LH; Durbin AP
PLoS One; 2008 Jul; 3(7):e2636. PubMed ID: 18612426
[TBL] [Abstract][Full Text] [Related]
34. Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion.
Singh AP; Puri SK; Chitnis CE
Mol Biochem Parasitol; 2002 Apr; 121(1):21-31. PubMed ID: 11985860
[TBL] [Abstract][Full Text] [Related]
35. Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant.
Xue X; Ding F; Zhang Q; Pan X; Qu L; Pan W
Vaccine; 2010 Apr; 28(18):3152-8. PubMed ID: 20197139
[TBL] [Abstract][Full Text] [Related]
36. Non-allele specific antibody responses to genetically distinct variant forms of Plasmodium vivax Duffy binding protein (PvDBP-II) in Iranians exposed to seasonal malaria transmission.
Valizadeh V; Zakeri S; Mehrizi AA; Djadid ND
Acta Trop; 2014 Aug; 136():89-100. PubMed ID: 24704284
[TBL] [Abstract][Full Text] [Related]
37. Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant.
Saul A; Lawrence G; Smillie A; Rzepczyk CM; Reed C; Taylor D; Anderson K; Stowers A; Kemp R; Allworth A; Anders RF; Brown GV; Pye D; Schoofs P; Irving DO; Dyer SL; Woodrow GC; Briggs WR; Reber R; Stürchler D
Vaccine; 1999 Aug; 17(23-24):3145-59. PubMed ID: 10462251
[TBL] [Abstract][Full Text] [Related]
38. Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51.
Herrera S; Fernández OL; Vera O; Cárdenas W; Ramírez O; Palacios R; Chen-Mok M; Corradin G; Arévalo-Herrera M
Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):12-20. PubMed ID: 21292873
[TBL] [Abstract][Full Text] [Related]
39. Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat region.
Yadava A; Hall CE; Sullivan JS; Nace D; Williams T; Collins WE; Ockenhouse CF; Barnwell JW
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3268. PubMed ID: 25329054
[TBL] [Abstract][Full Text] [Related]
40. Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.
Chen E; Salinas ND; Huang Y; Ntumngia F; Plasencia MD; Gross ML; Adams JH; Tolia NH
Proc Natl Acad Sci U S A; 2016 May; 113(22):6277-82. PubMed ID: 27194724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
